Latest Manufacturing News

Astron Limited and Energy Fuels have received a conditional Letter of Support from Export Finance Australia for up to A$80 million in senior debt financing, advancing the Donald Rare Earth and Mineral Sands Project toward production.

Arafura Rare Earths has received conditional approval for a US$100 million equity investment from Export Finance Australia, reinforcing the strategic importance of its Nolans Project in Australia’s critical minerals landscape.

Arafura Rare Earths has secured a non-binding Letter of Interest from the US Export-Import Bank for up to US$300 million to support its Nolans Project, enhancing the US rare earth supply chain and national security.

Imagion Biosystems has made significant strides toward filing an IND application for its MagSense® HER2 breast cancer imaging agent, supported by positive FDA feedback and a recent $3.5 million capital raise to fund upcoming clinical trials.

Nexsen Limited has initiated clinical trials for its StrepSure® GBS Rapid Sensor, a next-generation diagnostic device aimed at improving maternal health outcomes. The trial's success could pave the way for regulatory approval and early market penetration by the second half of 2026.

PMET Resources has completed a positive lithium-only feasibility study for its Shaakichiuwaanaan Project in Quebec, confirming technical and economic viability for a large-scale spodumene concentrate operation with a targeted final investment decision in 2027.

Sunrise Energy Metals has announced a significant 87% increase in the Ore Reserve Estimate for its Syerston Scandium Project, underpinning a 32-year mine life with steady scandium oxide production. The update comes amid tightening Chinese export controls, positioning the project as a critical non-Chinese scandium supply source.

Prominence Energy has extended its agreement to acquire the Gawler Hydrogen Project, allowing more time to secure final regulatory approvals and advance exploration in South Australia.

Radiopharm Theranostics has announced a $40 million equity raise via a two-tranche placement and a Share Purchase Plan (SPP) to fund its clinical programs and working capital. The offer includes new shares at $0.03 each with free attaching options, subject to shareholder approval.

United States Antimony Corporation has proposed acquiring Larvotto Resources in a deal that could create one of the largest antimony producers outside China, offering Larvotto shareholders a significant premium.

Mesoblast Limited reports a 69% jump in net revenues from its pioneering cell therapy Ryoncil in Q1 FY2026, propelled by expanded physician adoption and new reimbursement pathways. The company also secures convertible note funding and plans pivotal adult trials.

PolyNovo Limited reported a robust 33.3% increase in Q1 FY26 sales, driven by strong U.S. growth and a remarkable surge in NovoSorb MTX sales. The company also completed key infrastructure projects, positioning itself for further expansion.